sglt2 inhibition in type 1 diabetes | lori berard
Published 6 years ago • 319 plays • Length 1:53Download video MP4
Download video MP3
Similar videos
-
3:44
sglt2 inhibition in type 1 diabetes patients | john wilding
-
11:15
dissecting the canvas trial | carol wysham and lori berard
-
9:01
barriers to insulin: initiation in type 2 diabetes patients | lori berard
-
11:53
barriers to insulin: management in type 2 diabetes patients | lori berard
-
11:01
why sglt2 inhibitors cause euglycemic dka
-
59:11
hyperglycemia: treatment in type 2 diabetes with dr. merri pendergrass - march 03, 2022
-
1:00:55
sglt2i for evidence based cardiorenal protection in diabetic and non-diabetic chronic kidney disease
-
16:10
how sglt-2 inhibitors work: with pros and cons - jardiance, farxiga, invokana -type 2 diabetes#15
-
6:58
sglt2 inhibitors in t1d: 'people are using them now'
-
8:15
cgm devices and insulin dosing apps in hospital | pratik choudhary & lori berard
-
3:45
diabetes type 1 and type 2, animation.
-
4:27
diabetes device use in women admitted to the maternity unit | pratik choudhary & lori berard
-
4:21
the mechanism of sglt2 inhibition in glucose control
-
2:15
expert commentary: predictors of delayed insulin initiation in type 2 diabetes | lori berard
-
7:43
choosing sglt2 inhibitors vs glp-1 receptor agonists
-
3:23
what are sglt2 inhibitors - chronic kidney disease | uhl nhs trust
-
10:25
dr. rosendo - euglycemic dka
-
25:32
dr julie lovshin - sglt2i cardiorenal mechanisms in diabetes and beyond - full presentation
-
2:03
type 2 diabetes: the effects of different antidiabetic drug classes on mortality
-
59:01
initiating and managing sglt2 inhibitors in type 2 diabetes webinar
-
6:14
the daily debate - sglt-2 inhibitors and t1d
-
5:01
anti-diabetic oral drug sotagliflozin (sglt2 & sglt1 inhibitor)